{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:09:17Z","timestamp":1791162557991,"version":"4.1.0"},"reference-count":98,"publisher":"Oxford University Press (OUP)","issue":"1009","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The metabolic syndrome (MetS) represents a combination of cardiometabolic risk determinants including obesity (central adiposity), insulin resistance, glucose intolerance, dyslipidaemia, non-alcoholic fatty liver disease and hypertension. MetS is rapidly increasing in prevalence worldwide as a consequence of the continued obesity \u201cepidemic\u201d, and as a result will have a considerable impact on the global incidence of cardiovascular disease and type 2 diabetes. Currently, there is debate concerning whether the risk of cardiovascular disease is greater in patients diagnosed with MetS than that of the sum of the individual risk factors. At present, no unifying origin that can explain the pathogenesis of MetS has been identified and therefore no unique pharmacological treatment is available. This review summarises and critically evaluates the current clinical and scientific evidence supporting the existence of MetS as a multifactorial endocrine disease, for which maternal nutrition may be a common pathogenic mechanism. In addition, we suggest that ectopic fat accumulation (such as visceral and hepatic fat accumulation) and the proinflammatory state are central to the development of the MetS.<\/jats:p>","DOI":"10.1136\/pgmj.2008.078014","type":"journal-article","created":{"date-parts":[[2009,11,5]],"date-time":"2009-11-05T21:31:58Z","timestamp":1257456718000},"page":"614-621","source":"Crossref","is-referenced-by-count":126,"title":["The metabolic syndrome: common origins of a multifactorial disorder"],"prefix":"10.1093","volume":"85","author":[{"given":"K D","family":"Bruce","sequence":"first","affiliation":[{"name":"Endocrinology and Metabolism Unit, DOHaD Division, Institute of developmental Sciences, Southampton General Hospital , Southampton , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C D","family":"Byrne","sequence":"additional","affiliation":[{"name":"Endocrinology and Metabolism Unit, DOHaD Division, Institute of developmental Sciences, Southampton General Hospital , Southampton , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2009,11,5]]},"reference":[{"key":"2023041909293951900_b1","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Banting lecture 1988. Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"2023041909293951900_b2","first-page":"107","article-title":"Metabolic syndrome: therapeutic considerations","author":"Grundy","journal-title":"Handb Exp Pharmacol"},{"key":"2023041909293951900_b3","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1210\/jc.2006-0944","article-title":"Metabolic syndrome: a solution in search of a problem","volume":"92","author":"Ferrannini","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041909293951900_b4","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/ajcn\/83.6.1237","article-title":"The metabolic syndrome: is this diagnosis necessary?","volume":"83","author":"Reaven","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"2023041909293951900_b5","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1007\/s00125-005-1876-2","article-title":"The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes","volume":"48","author":"Kahn","year":"2005","journal-title":"Diabetologia"},{"key":"2023041909293951900_b6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/1753944707082662","article-title":"The metabolic syndrome as an endocrine disease: is there an effective pharmacotherapeutic strategy optimally targeting the pathogenesis?","volume":"1","author":"Schindler","year":"2007","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"2023041909293951900_b7","first-page":"139","article-title":"The metabolic syndrome and type 2 diabetes","volume":"30","author":"Poole","year":"2005","journal-title":"Minerva Endocrinol"},{"key":"2023041909293951900_b8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2337\/diacare.29.01.06.dc05-0862","article-title":"A single factor underlies the metabolic syndrome: a confirmatory factor analysis","volume":"29","author":"Pladevall","year":"2006","journal-title":"Diabetes Care"},{"key":"2023041909293951900_b9","volume-title":"WHO consultation: definition, diagnosis and clasification of diabetes mellitus and its complications","author":"World Health Organization","year":"1999"},{"key":"2023041909293951900_b10","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1046\/j.1464-5491.1999.00059.x","article-title":"Comment on the provisional report from the WHO consultation. European Group for the Study of Insulin Resistance (EGIR)","volume":"16","author":"Balkau","year":"1999","journal-title":"Diabet Med"},{"key":"2023041909293951900_b11","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"2023041909293951900_b12","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome: a new worldwide definition","volume":"366","author":"Alberti","journal-title":"Lancet"},{"key":"2023041909293951900_b13","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.numecd.2006.07.005","article-title":"The link between abdominal obesity, metabolic syndrome and cardiovascular disease","volume":"17","author":"Ritchie","year":"2007","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2023041909293951900_b14","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00000441-200506000-00008","article-title":"Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States","volume":"329","author":"Houston","year":"2005","journal-title":"Am J Med Sci"},{"key":"2023041909293951900_b15","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1056\/NEJMoa031049","article-title":"Obesity and the metabolic syndrome in children and adolescents","volume":"350","author":"Weiss","year":"2004","journal-title":"N Engl J Med"},{"key":"2023041909293951900_b16","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1001\/jama.282.16.1523","article-title":"The disease burden associated with overweight and obesity","volume":"282","author":"Must","year":"1999","journal-title":"JAMA"},{"key":"2023041909293951900_b17","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2337\/diacare.21.4.549","article-title":"Prevalence of glucose intolerance among Native Hawaiians in two rural communities. Native Hawaiian Health Research (NHHR) Project","volume":"21","author":"Grandinetti","year":"1998","journal-title":"Diabetes Care"},{"key":"2023041909293951900_b18","first-page":"250","article-title":"Prevalence of diabetes and glucose intolerance in an ethnically diverse rural community of Hawaii","volume":"17","author":"Grandinetti","year":"2007","journal-title":"Ethn Dis"},{"key":"2023041909293951900_b19","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1046\/j.1464-5491.2002.00737.x","article-title":"Glucose intolerance and associated factors in Mongolia: results of a national survey","volume":"19","author":"Suvd","year":"2002","journal-title":"Diabet Med"},{"key":"2023041909293951900_b20","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/sj.ijo.0802060","article-title":"Influence of obesity on cardiovascular risk. Twenty-three-year follow-up of 22,025 men from an urban Swedish population","volume":"26","author":"Jonsson","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"2023041909293951900_b21","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/oxfordjournals.aje.a009158","article-title":"Body fat distribution and risk of non-insulin-dependent diabetes mellitus in women. The Nurses\u2019 Health Study","volume":"145","author":"Carey","year":"1997","journal-title":"Am J Epidemiol"},{"key":"2023041909293951900_b22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11936-007-0021-6","article-title":"Adiposopathy: treating pathogenic adipose tissue to reduce cardiovascular disease risk","volume":"9","author":"Bays","year":"2007","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"2023041909293951900_b23","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1586\/14779072.6.3.343","article-title":"Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity","volume":"6","author":"Bays","year":"2008","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2023041909293951900_b24","first-page":"S26","article-title":"\u201cSick fat,\u201d metabolic disease, and atherosclerosis","author":"Bays","journal-title":"Am J Med"},{"key":"2023041909293951900_b25","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1161\/01.CIR.67.5.968","article-title":"Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study","volume":"67","author":"Hubert","year":"1983","journal-title":"Circulation"},{"key":"2023041909293951900_b26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0002-8703(99)70256-5","article-title":"Association of fasting blood sugar level, insulin level, and obesity with left ventricular mass in healthy children and adolescents: The Bogalusa Heart Study","volume":"138","author":"Urbina","year":"1999","journal-title":"Am Heart J"},{"key":"2023041909293951900_b27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2337\/diab.36.1.43","article-title":"Do upper-body and centralized adiposity measure different aspects of regional body-fat distribution? Relationship to non-insulin-dependent diabetes mellitus, lipids, and lipoproteins","volume":"36","author":"Haffner","year":"1987","journal-title":"Diabetes"},{"key":"2023041909293951900_b28","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1136\/bmj.311.7017.1401","article-title":"Waist circumference action levels in the identification of cardiovascular risk factors: prevalence study in a random sample","volume":"311","author":"Han","year":"1995","journal-title":"BMJ"},{"key":"2023041909293951900_b29","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.2337\/db06-1656","article-title":"Visceral fat adipokine secretion is associated with systemic inflammation in obese humans","volume":"56","author":"Fontana","year":"2007","journal-title":"Diabetes"},{"key":"2023041909293951900_b30","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2337\/diacare.28.2.385","article-title":"The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study","volume":"28","author":"McNeill","year":"2005","journal-title":"Diabetes Care"},{"key":"2023041909293951900_b31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1651-2227.2004.tb00241.x","article-title":"Atherosclerosis and the immune system","volume":"93","author":"Hansson","year":"2004","journal-title":"Acta Paediatr Suppl"},{"key":"2023041909293951900_b32","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/ajcn\/79.4.682","article-title":"Increase in intranuclear nuclear factor kappaB and decrease in inhibitor kappaB in mononuclear cells after a mixed meal: evidence for a proinflammatory effect","volume":"79","author":"Aljada","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"2023041909293951900_b33","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1161\/01.CIR.0000158483.13093.9D","article-title":"Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation","volume":"111","author":"Dandona","year":"2005","journal-title":"Circulation"},{"key":"2023041909293951900_b34","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/00000441-200512000-00006","article-title":"The key role of insulin resistance in the cardiometabolic syndrome","volume":"330","author":"Gill","year":"2005","journal-title":"Am J Med Sci"},{"key":"2023041909293951900_b35","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00125-004-1433-4","article-title":"Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies","volume":"47","author":"Hu","year":"2004","journal-title":"Diabetologia"},{"key":"2023041909293951900_b36","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.2337\/diabetes.51.7.2325","article-title":"Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome","volume":"51","author":"Kondo","year":"2002","journal-title":"Diabetes"},{"key":"2023041909293951900_b37","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1016\/j.febslet.2006.04.028","article-title":"The metabolic syndrome and adipocytokines","volume":"580","author":"Matsuzawa","journal-title":"FEBS Lett"},{"key":"2023041909293951900_b38","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-59745-370-7","volume-title":"Adipose tissue and adipokines in health and disease","author":"Fantuzzi","year":"2007"},{"key":"2023041909293951900_b39","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1210\/jc.2004-1579","article-title":"The association between abdominal visceral fat and carotid stiffness is mediated by circulating inflammatory markers in uncomplicated type 2 diabetes","volume":"90","author":"Diamant","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041909293951900_b40","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2174\/1566524053766022","article-title":"Insulin resistance in type 2 diabetes: role of the adipokines","volume":"5","author":"Arner","year":"2005","journal-title":"Curr Mol Med"},{"key":"2023041909293951900_b41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2796.2004.01426.x","article-title":"Adiponectin: journey from an adipocyte secretory protein to biomarker of the metabolic syndrome","volume":"257","author":"Trujillo","year":"2005","journal-title":"J Intern Med"},{"key":"2023041909293951900_b42","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(02)09335-2","article-title":"Adiponectin and development of type 2 diabetes in the Pima Indian population","volume":"360","author":"Lindsay","year":"2002","journal-title":"Lancet"},{"key":"2023041909293951900_b43","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/01.ATV.20.6.1595","article-title":"Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients","volume":"20","author":"Hotta","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2023041909293951900_b44","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jcem.86.5.7463","article-title":"Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia","volume":"86","author":"Weyer","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041909293951900_b45","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1172\/JCI14120","article-title":"Endogenous glucose production is inhibited by the adipose-derived protein Acrp30","volume":"108","author":"Combs","year":"2001","journal-title":"J Clin Invest"},{"key":"2023041909293951900_b46","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1073\/pnas.98.4.2005","article-title":"Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice","volume":"98","author":"Fruebis","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2023041909293951900_b47","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","article-title":"The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity","volume":"7","author":"Yamauchi","year":"2001","journal-title":"Nat Med"},{"key":"2023041909293951900_b48","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1161\/01.ATV.20.6.1595","article-title":"Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients","volume":"20","author":"Hotta","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2023041909293951900_b49","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1161\/01.HYP.0000129281.03801.4b","article-title":"Hypoadiponectinemia is an independent risk factor for hypertension","volume":"43","author":"Iwashima","year":"2004","journal-title":"Hypertension"},{"key":"2023041909293951900_b50","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nri1937","article-title":"Adipocytokines: mediators linking adipose tissue, inflammation and immunity","volume":"6","author":"Tilg","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"2023041909293951900_b51","first-page":"647","article-title":"Role of insulin resistance and hyperinsulinemia in development of hypertension and atherosclerosis","volume":"123","author":"Sowers","year":"1994","journal-title":"J Lab Clin Med"},{"key":"2023041909293951900_b52","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.2337\/db08-1688","article-title":"Muscle microvascular dysfunction in central obesity is related to muscle insulin insensitivity but is not reversed by high-dose statin treatment","volume":"58","author":"Clough","year":"2009","journal-title":"Diabetes"},{"key":"2023041909293951900_b53","first-page":"E425","article-title":"Relationship of visceral adipose tissue and glucose disposal is independent of sex in black NIDDM subjects","volume":"273","author":"Banerji","year":"1997","journal-title":"Am J Physiol"},{"key":"2023041909293951900_b54","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2337\/diacare.19.6.629","article-title":"The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men","volume":"19","author":"Tchernof","year":"1996","journal-title":"Diabetes Care"},{"key":"2023041909293951900_b55","first-page":"S57","article-title":"Role of body fat distribution and the metabolic complications of obesity","author":"Jensen","journal-title":"J Clin Endocrinol Metab"},{"issue":"(Suppl 8A)","key":"2023041909293951900_b56","doi-asserted-by":"crossref","first-page":"29S","DOI":"10.1016\/j.amjmed.2003.09.004","article-title":"Free fatty acids and type 2 diabetes mellitus","volume":"115","author":"Wyne","year":"2003","journal-title":"Am J Med"},{"key":"2023041909293951900_b57","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hep.21496","article-title":"The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD","volume":"45","author":"Angulo","year":"2007","journal-title":"Hepatology"},{"key":"2023041909293951900_b58","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hep.20734","article-title":"Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study","volume":"42","author":"Bedogni","year":"2005","journal-title":"Hepatology"},{"key":"2023041909293951900_b59","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"2023041909293951900_b60","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jhep.2005.02.042","article-title":"Prevalence of and risk factors for fatty liver in a general population of Shanghai, China","volume":"43","author":"Fan","year":"2005","journal-title":"J Hepatol"},{"key":"2023041909293951900_b61","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00125-005-0070-x","article-title":"Non-esterified fatty acid concentrations are independently associated with hepatic steatosis in obese subjects","volume":"49","author":"Holt","year":"2006","journal-title":"Diabetologia"},{"key":"2023041909293951900_b62","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1210\/jc.2007-0482","article-title":"Liver fat in the metabolic syndrome","volume":"92","author":"Kotronen","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041909293951900_b63","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1001\/jama.282.17.1659","article-title":"Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study","volume":"282","author":"Cortez-Pinto","year":"1999","journal-title":"JAMA"},{"key":"2023041909293951900_b64","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1210\/jcem.84.5.5661","article-title":"Liver pathology and the metabolic syndrome X in severe obesity","volume":"84","author":"Marceau","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2023041909293951900_b65","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: a feature of the metabolic syndrome","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"key":"2023041909293951900_b66","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s00125-008-1135-4","article-title":"Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?","volume":"51","author":"Targher","year":"2008","journal-title":"Diabetologia"},{"key":"2023041909293951900_b67","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/ATVBAHA.107.147538","article-title":"Fatty liver: a novel component of the metabolic syndrome","volume":"28","author":"Kotronen","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2023041909293951900_b68","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1194\/jlr.M500294-JLR200","article-title":"Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans","volume":"46","author":"Cinti","year":"2005","journal-title":"J Lipid Res"},{"key":"2023041909293951900_b69","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.2337\/db07-0111","article-title":"Adipose tissue inflammation and increased ceramide content characterize subjects with high liver fat content independent of obesity","volume":"56","author":"Kolak","year":"2007","journal-title":"Diabetes"},{"key":"2023041909293951900_b70","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1172\/JCI26498","article-title":"MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity","volume":"116","author":"Kanda","year":"2006","journal-title":"J Clin Invest"},{"key":"2023041909293951900_b71","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm1166","article-title":"Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB","volume":"11","author":"Cai","year":"2005","journal-title":"Nat Med"},{"key":"2023041909293951900_b72","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.tem.2008.08.005","article-title":"Insulin resistance, inflammation, and non-alcoholic fatty liver disease","volume":"19","author":"Tilg","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"2023041909293951900_b73","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J Clin Invest"},{"key":"2023041909293951900_b74","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1042\/CS20080253","article-title":"Metabolic disturbances in non-alcoholic fatty liver disease","volume":"116","author":"Byrne","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"2023041909293951900_b75","article-title":"Maternal high fat feeding primes the development of progressive non alchoholic fatty liver disease in adult offspring","author":"Bruce","year":"2009"},{"key":"2023041909293951900_b76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2005.10.004","article-title":"Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it","volume":"6","author":"Begriche","year":"2006","journal-title":"Mitochondrion"},{"key":"2023041909293951900_b77","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0168-8278(99)80033-6","article-title":"Mitochondrial abnormalities in non-alcoholic steatohepatitis","volume":"31","author":"Caldwell","year":"1999","journal-title":"J Hepatol"},{"key":"2023041909293951900_b78","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/01.mco.0000241677.40170.17","article-title":"Non-alcoholic steatohepatitis and metabolic syndrome","volume":"9","author":"Machado","year":"2006","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"2023041909293951900_b79","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/hep.1840380426","article-title":"Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis","volume":"38","author":"Perez-Carreras","year":"2003","journal-title":"Hepatology"},{"issue":"(Suppl 1)","key":"2023041909293951900_b80","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1111\/j.1440-1746.2006.04640.x","article-title":"Role of mitochondria in non-alcoholic fatty liver disease","volume":"22","author":"Pessayre","year":"2007","journal-title":"J Gastroenterol Hepatol"},{"key":"2023041909293951900_b81","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2362.2008.01936.x","article-title":"Alterations of hepatic ATP homeostasis and respiratory chain during development of non-alcoholic steatohepatitis in a rodent model","volume":"38","author":"Serviddio","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"2023041909293951900_b82","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1023\/A:1027344914565","article-title":"Membrane-linked systems preventing superoxide formation","volume":"17","author":"Skulachev","year":"1997","journal-title":"Biosci Rep"},{"key":"2023041909293951900_b83","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/oby.2008.10","article-title":"Alterations in hepatic mitochondrial compartment in a model of obesity and insulin resistance","volume":"16","author":"Raffaella","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"2023041909293951900_b84","doi-asserted-by":"crossref","first-page":"R134","DOI":"10.1152\/ajpregu.00355.2004","article-title":"Impaired glucose homeostasis and mitochondrial abnormalities in offspring of rats fed a fat-rich diet in pregnancy","volume":"288","author":"Taylor","year":"2005","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2023041909293951900_b85","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1126\/science.1077780","article-title":"Rates of behavior and aging specified by mitochondrial function during development","volume":"298","author":"Dillin","year":"2002","journal-title":"Science"},{"key":"2023041909293951900_b86","first-page":"671","article-title":"Opinion number 315, September 2005. Obesity in pregnancy","volume":"106","author":"ACOG Committee","year":"2005","journal-title":"Obstet Gynecol"},{"key":"2023041909293951900_b87","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1146\/annurev.nutr.24.012003.132249","article-title":"Maternal obesity, metabolism, and pregnancy outcomes","volume":"26","author":"King","year":"2006","journal-title":"Annu Rev Nutr"},{"key":"2023041909293951900_b88","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1096\/fj.08-116889","article-title":"High-fat diet before and during pregnancy causes marked up-regulation of placental nutrient transport and fetal overgrowth in C57\/BL6 mice","volume":"23","author":"Jones","year":"2009","journal-title":"FASEB J"},{"key":"2023041909293951900_b89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1462399402005240","article-title":"Pre- and early postnatal nongenetic determinants of type 2 diabetes","volume":"4","author":"Ozanne","year":"2002","journal-title":"Expert Rev Mol Med"},{"key":"2023041909293951900_b90","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1161\/HYPERTENSIONAHA.107.101477","article-title":"Diet-induced obesity in female mice leads to offspring hyperphagia, adiposity, hypertension, and insulin resistance: a novel murine model of developmental programming","volume":"51","author":"Samuelsson","year":"2008","journal-title":"Hypertension"},{"key":"2023041909293951900_b91","doi-asserted-by":"crossref","first-page":"E792","DOI":"10.1152\/ajpendo.00078.2006","article-title":"Maternal high-fat diet consumption results in fetal malprogramming predisposing to the onset of metabolic syndrome-like phenotype in adulthood","volume":"291","author":"Srinivasan","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2023041909293951900_b92","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1113\/expphysiol.2005.032854","article-title":"Developmental programming of obesity in mammals","volume":"92","author":"Taylor","year":"2007","journal-title":"Exp Physiol"},{"key":"2023041909293951900_b93","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/bmj.301.6746.259","article-title":"Fetal and placental size and risk of hypertension in adult life","volume":"301","author":"Barker","year":"1990","journal-title":"BMJ"},{"key":"2023041909293951900_b94","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/0140-6736(93)91224-A","article-title":"Fetal nutrition and cardiovascular disease in adult life","volume":"341","author":"Barker","year":"1993","journal-title":"Lancet"},{"key":"2023041909293951900_b95","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1210\/en.2005-0246","article-title":"Maternal nutritional programming of fetal adipose tissue development: differential effects on messenger ribonucleic acid abundance for uncoupling proteins and peroxisome proliferator-activated and prolactin receptors","volume":"146","author":"Bispham","year":"2005","journal-title":"Endocrinology"},{"key":"2023041909293951900_b96","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/s00125-002-0833-6","article-title":"Taurine supplementation to a low protein diet during foetal and early postnatal life restores a normal proliferation and apoptosis of rat pancreatic islets","volume":"45","author":"Boujendar","year":"2002","journal-title":"Diabetologia"},{"key":"2023041909293951900_b97","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1172\/JCI112678","article-title":"Preweaning food intake influences the adiposity of young adult baboons","volume":"78","author":"Lewis","year":"1986","journal-title":"J Clin Invest"},{"key":"2023041909293951900_b98","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/85\/1009\/614\/50020787\/postgradmedj-85-614.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/85\/1009\/614\/50020787\/postgradmedj-85-614.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T09:45:22Z","timestamp":1681897522000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/85\/1009\/614\/7019283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11,1]]},"references-count":98,"journal-issue":{"issue":"1009","published-online":{"date-parts":[[2009,11,5]]},"published-print":{"date-parts":[[2009,11,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.2008.078014","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2009,11]]},"published":{"date-parts":[[2009,11,1]]}}}